This week we attended the @oxfordcancer.bsky.social and the @britsocimm.bsky.social -Oxford symposium 👩🏼💻🗒️👨💻
We are proud to share that at BSI-Oxford, our PostDoc @nabinapun.bsky.social won the prize for the best talk & our RA Paul won the best poster!
💪🏆🎉👏
Withers lab represent!
Already getting stuck in to an awesome 2026 with DPhil triage interviews starting on Monday for our CRUK centre core funded programme in Cancer Sciences with a pathway in cancer immunology.
Great to see that @oxcio.bsky.social Max is thinking big before his DPhil viva this morning! #croissantasaurusrex
Great discussion - patient groups are central to A/I partnerships -especially in the ED/prevention space….
Congratulations Liz! Read her historical perspective article in @imtadvances.bsky.social
Congress starts today in Liverpool. Immunologists are battling the elements to be together! See you there.
🧬 Therapeutic cancer vaccines are back in focus! Advances in neo-antigen T cells, dendritic cell biology, and mRNA tech are paving the way for next-gen immunotherapy.
Read the Open Access review: https://bit.ly/4cefxGm
#CancerVaccines #Immunotherapy #mRNA #Oncology
🦠 DC3s in solid tumours can prime T cells and influence outcomes—boosting survival in some cancers, but promoting immunosuppression in others.
👉 https://bit.ly/3T2blRg
#Immunotherapy #CancerImmunology
🔬 First head-to-head comparison of nuclear imaging for tumour CD8⁺ T cells shows [⁸⁹Zr]Zr-anti-CD8-IgG2a(silent) & [⁸⁹Zr]Zr-OT-I track T-cell infiltration & migration, aiding immunotherapy strategies.
👉 https://bit.ly/4ncWCzv
#Immunotherapy #CD8Tcells #CancerResearch
Congratulations, Michael! 🎉
Agreed. Pipette for Power!
It seems someone removed the beautiful local multinational flag from the lamppost in East Oxford, but someone else has put up another one.
nextdoor.co.uk/p/8TdLxGqcS_...
Incredible #infection #immunity #cancer #Bcells #Tcells Resource 👏 Top of the Human League 🙋♂️🙋♀️
From CAR-NK cells to checkpoint inhibitors, Blunt & Khakoo review how boosting NK-cell function could transform cancer therapy.
🔓 Open access: https://bit.ly/4j8dKEW
#Immunotherapy #NKcells #CancerResearch
UK NK 2026 in Cardiff.
January 9th. Be there.
eventbrite.co.uk/e/uk-nk-confer…
Hosted by Rich Stanton, Ceri Fielding & Eddie Wang
Need funding to attend your next conference? 💡
The BSI Conference Travel Grants can cover your travel costs - UK (£500), Europe (£700), rest of world (£1,000).
The deadline is just over 1 week away (1 November), so submit your application soon! https://bit.ly/3U0jk2E
@witherslab.bsky.social going from strength to strength
Tick what? Many happy returns Felipe and well marked Anjum!
4 decades of IO – Celebrating 40 years of SITC. In 2009, we had a record meeting attendance and abstract submission! Attend this year's 40th Anniversary Annual Meeting and be a part of the science. https://www.sitcancer.org/2025/home
Wonderful day celebrating Paul Nurse after he steps down from being the Director @crick.ac.uk. We are all very grateful to him for having created an amazing institute.
@blackwellbooks.bsky.social please start posting
Great to see our work on preventive cancer vaccines, including LungVax, featured in this issue!
@oxfordcancer.bsky.social @sarahblagden.bsky.social @timmunologist.bsky.social
Join us for our DPhil in Cancer Science Open Day on Tuesday 2nd September at 12:30pm to find out how a DPhil can be the next step in your cancer research career development!
Register via our Eventbrite link before 1st Sept⬇️ @oncology.ox.ac.uk @medsci.ox.ac.uk
www.eventbrite.co.uk/e/university...
Looking forward to talking about #cancervaccines to *all* @CRUK research and innovation staff this afternoon at their fabulous away-day. Actually I’m a bit nervous😬
Amazing news for our Institute @kiroxford.bsky.social @ox.ac.uk 🎉🍾😀 ! Looking forward to working with our @manchester.ac.uk colleagues to understand better how envrionmental determinants drive chronic inflammatory diseases !
Targeting monocyte dynamics in MS?
In Immunotherapy Advances, Bibi et al. explore how shifting monocytes from inflammatory to reparative states may reshape MS treatment strategies.
📘 https://bit.ly/3EXOfaV
#MS #Monocytes #Neuroinflammation
New research by Rui Zhao et al. shows that high anti-drug antibody (ADA) levels after 3 cycles of camrelizumab are linked to shorter survival in patients with advanced solid cancers.
📉 Higher ADA = lower drug levels = worse outcomes.
🔗 https://bit.ly/461mc5B
#Immunotherapy #CancerResearch
🧬 Better understanding of immune rejection and evasion is setting the stage for next-gen therapies.
Elizabeth Simpson reviews how foundational immunology is reshaping transplant and cancer treatment.
📖 https://bit.ly/44N141N
#TransplantImmunology #Immunotherapy
🧩 Antigen presentation is complex - but imaging is bringing clarity.
@doreenlau.bsky.social & @timmunologist.bsky.social review how advanced imaging illuminates T-cell–APC interactions, peptide-MHC dynamics, and more in cancer immunity.
📖 https://bit.ly/3TkIasN
#CancerImmunology
